A detailed history of Bsw Wealth Partners transactions in Novartis Ag stock. As of the latest transaction made, Bsw Wealth Partners holds 7,727 shares of NVS stock, worth $796,190. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,727
Previous 7,090 8.98%
Holding current value
$796,190
Previous $754,000 17.77%
% of portfolio
0.13%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$106.13 - $120.89 $67,604 - $77,006
637 Added 8.98%
7,727 $888,000
Q2 2024

Jul 16, 2024

SELL
$92.57 - $107.37 $44,989 - $52,181
-486 Reduced 6.41%
7,090 $754,000
Q1 2024

Apr 23, 2024

SELL
$95.27 - $108.47 $75,739 - $86,233
-795 Reduced 9.5%
7,576 $732,000
Q4 2023

Jan 25, 2024

BUY
$92.27 - $101.54 $134,345 - $147,842
1,456 Added 21.06%
8,371 $845,000
Q3 2023

Oct 27, 2023

SELL
$94.73 - $105.13 $11,462 - $12,720
-121 Reduced 1.72%
6,915 $704,000
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $11,565 - $13,113
-125 Reduced 1.75%
7,036 $710,000
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $145,574 - $168,821
-1,819 Reduced 20.26%
7,161 $658,000
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $93,304 - $114,262
1,235 Added 15.95%
8,980 $814,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $58,270 - $68,150
-781 Reduced 9.16%
7,745 $589,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $13,849 - $16,125
172 Added 2.06%
8,526 $721,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $209,647 - $237,152
2,617 Added 45.62%
8,354 $733,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $129,432 - $143,123
-1,624 Reduced 22.06%
5,737 $502,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $327,937 - $381,511
4,010 Added 119.67%
7,361 $602,000
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $285,639 - $315,496
3,351 New
3,351 $306,000
Q4 2017

Feb 08, 2018

SELL
$72.33 - $77.64 $184,730 - $198,292
-2,554 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$74.14 - $77.27 $189,353 - $197,347
2,554
2,554 $219,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.